Flagship resource
Infusion Centre Economics Model
A quick planning-level model for chair economics. For a decision involving real capital, request the full pro forma — this adds payer mix, drug cost and 340B overlay.
- Browser tool
- Planning-level estimate only
What drives the number
Chair count and utilization set the ceiling on volume.
Everything else — payer mix, drug cost, staffing — determines what that volume is actually worth. This model gives a directional first read before the full pro forma.
Try it
Enter your own assumptions.
A directional estimate only — see the disclaimer below the results.
Inputs05 variables
Estimated monthly infusions
252
Estimated monthly gross revenue
$163,592
A directional planning estimate only — it does not include payer mix, drug acquisition cost, 340B overlay, staffing cost or site-of-care effects. A full pro forma models all of those together against your actual volumes.
02 links